These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 20112683)

  • 1. [Expression, purification and immunogenicity of human papillomavirus type 11 virus-like particles from Escherichia coli].
    Yan C; Li S; Wang J; Wei M; Huang B; Zhuang Y; Li Z; Pan H; Zhang J; Xia N
    Wei Sheng Wu Xue Bao; 2009 Nov; 49(11):1527-33. PubMed ID: 20112683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression, purification and immunogenicity analysis of HPV type 18 virus-like particles from Escherichia coli].
    Xie M; Li S; Shen W; Li Z; Zhuang Y; Mo X; Gu Y; Wu T; Zhang J; Xia N
    Sheng Wu Gong Cheng Xue Bao; 2009 Jul; 25(7):1082-7. PubMed ID: 19835152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of human papillomavirus type 33 L1 major capsid protein and virus-like particles from Bacillus subtilis to develop a prophylactic vaccine against cervical cancer.
    Baek JO; Seo JW; Kwon O; Park SM; Kim CH; Kim IH
    Enzyme Microb Technol; 2012 Mar; 50(3):173-80. PubMed ID: 22305172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prokaryotic expression and purification of human papillomavirus type 11 L2E7 fusion protein vaccine and its immunnogenicity].
    Zhang H; Zhao L; Ren J; Gao J; Bian T; Fan JT; Ruan L; Chen XQ; Tian HW
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Jun; 21(2):156-8. PubMed ID: 17653322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacterially expressed human papillomavirus type 6 and 11 bivalent vaccine: Characterization, antigenicity and immunogenicity.
    Pan H; Li Z; Wang J; Song S; Wang D; Wei M; Gu Y; Zhang J; Li S; Xia N
    Vaccine; 2017 May; 35(24):3222-3231. PubMed ID: 28483196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Production of human papillomavirus type 16 virus-like particles and its immunogenicity].
    Wei MX; Li SW; Huang B; Shen WT; Su YZ; Zhang CH; Gu Y; Du HL; Zhang J; Xia NS
    Bing Du Xue Bao; 2009 Jul; 25(4):245-50. PubMed ID: 19769155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production and purification of human papillomavirus type 33 L1 virus-like particles from Spodoptera frugiperda 9 cells using two-step column chromatography.
    Baek JO; Seo JW; Kim IH; Kim CH
    Protein Expr Purif; 2011 Feb; 75(2):211-7. PubMed ID: 20716445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human papillomavirus L1 protein expressed in Escherichia coli self-assembles into virus-like particles that are highly immunogenic.
    Chen Y; Liu Y; Zhang G; Wang A; Dong Z; Qi Y; Wang J; Zhao B; Li N; Jiang M
    Virus Res; 2016 Jul; 220():97-103. PubMed ID: 27107614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HPV11 mutant virus-like particles elicit immune responses that neutralize virus and delineate a novel neutralizing domain.
    Ludmerer SW; McClements WL; Wang XM; Ling JC; Jansen KU; Christensen ND
    Virology; 2000 Jan; 266(2):237-45. PubMed ID: 10639310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles.
    Boxus M; Fochesato M; Miseur A; Mertens E; Dendouga N; Brendle S; Balogh KK; Christensen ND; Giannini SL
    J Virol; 2016 Jul; 90(14):6314-25. PubMed ID: 27147749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Construction and immunogenicity evaluation of chimerical DNA vaccine of human papillomavirus type 11].
    Huang ZH; Li LH; Guo ZJ; Liu ZH; Ren JD; Song MX; Zhou XK; Wang F; Bi ZG
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Jun; 23(3):182-4. PubMed ID: 20104772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papillomavirus type 58 L1 virus-like particles purified by two-step chromatography elicit high levels of long-lasting neutralizing antibodies.
    Xie X; Liu Y; Zhang T; Xu Y; Bao Q; Chen X; Liu H; Xu X
    Arch Virol; 2013 Jan; 158(1):193-9. PubMed ID: 22965579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of HPV-11 L1 protein in transgenic Arabidopsis thaliana and Nicotiana tabacum.
    Kohl TO; Hitzeroth II; Christensen ND; Rybicki EP
    BMC Biotechnol; 2007 Sep; 7():56. PubMed ID: 17850660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification and immunogenicity study of human papillomavirus type 16 L1 protein in Saccharomyces cerevisiae.
    Kim SN; Jeong HS; Park SN; Kim HJ
    J Virol Methods; 2007 Jan; 139(1):24-30. PubMed ID: 17034867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of anti-HPV11-L1 antibodies in immune sera from patients suffering from recurrent respiratory papillomatosis using ELISA.
    Durzyńska J; Błazejewska P; Szydłowski J; Goździcka-Józefiak A
    Viral Immunol; 2010 Aug; 23(4):415-23. PubMed ID: 20712486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-terminal truncations on L1 proteins of human papillomaviruses promote their soluble expression in Escherichia coli and self-assembly in vitro.
    Wei M; Wang D; Li Z; Song S; Kong X; Mo X; Yang Y; He M; Li Z; Huang B; Lin Z; Pan H; Zheng Q; Yu H; Gu Y; Zhang J; Li S; Xia N
    Emerg Microbes Infect; 2018 Sep; 7(1):160. PubMed ID: 30254257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification and immunogenicity study of human papillomavirus 58 virus-like particles expressed in Pichia pastoris.
    Jiang Z; Tong G; Cai B; Xu Y; Lou J
    Protein Expr Purif; 2011 Dec; 80(2):203-10. PubMed ID: 21821128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient expression and purification of porcine circovirus type 2 virus-like particles in Escherichia coli.
    Wu PC; Chen TY; Chi JN; Chien MS; Huang C
    J Biotechnol; 2016 Feb; 220():78-85. PubMed ID: 26795354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical model to test human papillomavirus virus (HPV) capsid vaccines in vivo using infectious HPV/cottontail rabbit papillomavirus chimeric papillomavirus particles.
    Mejia AF; Culp TD; Cladel NM; Balogh KK; Budgeon LR; Buck CB; Christensen ND
    J Virol; 2006 Dec; 80(24):12393-7. PubMed ID: 17005666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Refining HPV 16 L1 purification from E. coli: reducing endotoxin contaminations and their impact on immunogenicity.
    Schädlich L; Senger T; Kirschning CJ; Müller M; Gissmann L
    Vaccine; 2009 Mar; 27(10):1511-22. PubMed ID: 19174177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.